Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GeneLink names new CEO

This article was originally published in Clinica

Executive Summary

Gary Beeman has been appointed CEO and president of consumer genomics specialist GeneLink BioSciences. He replaces interim CEO David Macdonald, who will continue to work with GeneLink (Longwood, Florida) in a consulting capacity. Most recently, Mr Beeman was CEO and founder of Bay Hill Ventures, a private capital firm. He has also served as strategic planning director for GeneLink’s board, and director of marketing communications for GeneWize Life Sciences, a subsidiary of GeneLink. Meanwhile, Sharon Tahaney has been named president of GeneWize. She was previously senior vice-president of sales and marketing at the company.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts